Skip to main content

Find Clinical Trials

Home
Conditions
Systemic Vasculitis

Clinical trial condition

Systemic Vasculitis

Explore clinical trials studying Systemic Vasculitis. Study availability and eligibility vary by location and protocol.

187 public trials 67 recruiting studies

Refine in advanced search Browse all conditions

Systemic Vasculitis trial results

Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

NCT03004326

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Autoimmune Diseases, +46 more
Locations: University of California, Los Angeles Los Angeles, California, United States

Boston University School of Medicine Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

NCT07315087

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +15 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

NCT06614270

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +21 more
Locations: the second affiliated hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

NCT07275190

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
Locations: Fondazione IRCCS Policlinico San Matteo, SC Reumatologia Pavia, Italy

View Trial Details

Recruiting

A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

NCT05979051

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations: Beijing Hospital Beijing, Beijing Municipality, China

The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis

NCT07151521

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Ruiiin Hospital Shanghai JiaoTong University School of Medicine Shanghai, China

View Trial Details

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

NCT06941129

Conditions: ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

NCT07150000

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +55 more
Locations: University Hospital, Bonn Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT06980597

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Beijing Boren Hospital Beijing, China

Beijing GoBroad Hospital Beijing, China

View Trial Details